TY - JOUR
T1 - The prevalence and demographic features of congenital cytomegalovirus infection in an urban area of East Asia
T2 - A population-based study
AU - Yang, Tzong-Hann
AU - Huang, Hung-Meng
AU - Hsu, Wei-Chung
AU - Tsao, Po-Nien
AU - Liu, Tien-Chen
AU - Hsu, Chuan-Jen
AU - Huang, Li-Min
AU - Wu, Chuan-Song
AU - Weng, Shih-Ming
AU - Lu, Chun-Yi
AU - Wu, Chen-Chi
N1 - Funding Information:
The study was supported by research grants from the National Taiwan University Hospital (107-S3913), Taipei City Government (10501- 62- 030), and the Ministry of Science and Technology, Taiwan (107-2622-B-002-008-CC2.
Publisher Copyright:
© 2021 Yang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PY - 2021/3
Y1 - 2021/3
N2 - Congenital cytomegalovirus (cCMV) infection is the leading environmental cause of childhood hearing impairment. However, its significance remains largely undocumented in many regions of the world. The purpose of this study was to investigate the prevalence and clinical features of cCMV infection in East Asia. Neonates born at a municipal hospital in Taipei were prospectively recruited and underwent concurrent hearing and CMV screenings. Those who failed the hearing screening or screened positive for CMV were subjected to a focused audiological and/or virological surveillance. The characteristics of the newborns and their mothers were compared between the CMV-positive and CMV-negative groups. Of the 1,532 newborns who underwent concurrent hearing and CMV screenings, seven (0.46%) were positive for cCMV infection. All seven CMV-positive newborns were asymptomatic at birth, and none of them developed hearing or other symptoms during a follow-up period of 14.4±6.3 months. The mothers of the CMV-positive newborns demonstrated higher gravidity (2.4 ± 1.4 vs. 2.1 ± 1.2) and parity (2.0 ± 1.2 vs. 1.6 ± 0.7) than those in the CMV-negative group; however, the difference did not reach statistical significance. The prevalence of cCMV infection in Taipei newborns was 0.46%, which is slightly lower than that of other populations and that of a previous report in the Taiwanese population. The relatively low prevalence in this study might be attributed to the improved public health system and decreased fertility rate in Taiwan.
AB - Congenital cytomegalovirus (cCMV) infection is the leading environmental cause of childhood hearing impairment. However, its significance remains largely undocumented in many regions of the world. The purpose of this study was to investigate the prevalence and clinical features of cCMV infection in East Asia. Neonates born at a municipal hospital in Taipei were prospectively recruited and underwent concurrent hearing and CMV screenings. Those who failed the hearing screening or screened positive for CMV were subjected to a focused audiological and/or virological surveillance. The characteristics of the newborns and their mothers were compared between the CMV-positive and CMV-negative groups. Of the 1,532 newborns who underwent concurrent hearing and CMV screenings, seven (0.46%) were positive for cCMV infection. All seven CMV-positive newborns were asymptomatic at birth, and none of them developed hearing or other symptoms during a follow-up period of 14.4±6.3 months. The mothers of the CMV-positive newborns demonstrated higher gravidity (2.4 ± 1.4 vs. 2.1 ± 1.2) and parity (2.0 ± 1.2 vs. 1.6 ± 0.7) than those in the CMV-negative group; however, the difference did not reach statistical significance. The prevalence of cCMV infection in Taipei newborns was 0.46%, which is slightly lower than that of other populations and that of a previous report in the Taiwanese population. The relatively low prevalence in this study might be attributed to the improved public health system and decreased fertility rate in Taiwan.
UR - http://www.scopus.com/inward/record.url?scp=85103292551&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85103292551&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0248801
DO - 10.1371/journal.pone.0248801
M3 - Article
C2 - 33765031
SN - 1932-6203
VL - 16
SP - e0248801
JO - PLoS ONE
JF - PLoS ONE
IS - 3 March
M1 - e0248801
ER -